Gut infection test gets FDA go-ahead

BD Diagnostics, of Sparks, a segment of Becton, Dickinson & Co., a global medical technology company, announced it has received U.S. Food and Drug Administration clearance to market the BD MAX Cdiff Assay in the United States.

Leave a Reply

Your email address will not be published. Required fields are marked *